Skip to main content
. Author manuscript; available in PMC: 2016 May 16.
Published in final edited form as: Gynecol Oncol. 2015 Apr 28;138(1):109–114. doi: 10.1016/j.ygyno.2015.04.029

Table 3. Demographics stratified by referral to genetics.

Referred Not referred p-Value
Total 178 (21.7%) 642 (78.3%)
Age at diagnosis (n = 178) (n = 642)
 Mean (SD) 44.6 (9.1) 51.7 (12.6) <0.0001a
 Median (min–max) 44 (24–75) 48 (22–89)
Stage at diagnosis (n = 178) (n = 634)
 0–II 139 (78.1) 403 (63.6) 0.0003b
 III–IV 39 (21.9) 231 (36.4)
Race/ethnicity (n = 171) (n = 591)
 Caucasian 153 (89.5) 546 (92.4) 0.08c
 African American 5 (2.9) 19 (3.2)
 Hispanic 13 (7.6) 18 (3.1)
 American Indian/Eskimo 0 (–) 2 (0.3)
 Asian 0 (–) 6 (1.0)
Insurance (n = 162) (n = 600)
 Private/managed care 126 (77.8) 407 (67.8) 0.05b
 Medicaid/Medicare 32 (19.7) 170 (28.3)
 Uninsured 4 (2.5) 23 (3.8)
Family history of cancer (n = 172) (n = 459)
 Yes 131 (76.2) 211 (46.0) <0.0001b
 No 41 (23.8) 248 (54.0)
Parity (n = 173) (n = 519)
 Nuliparous 39 (22.5) 151 (29.1) 0.09b
 Parous 134 (77.5) 368 (70.9)

Besides total numbers, all percents listed are column percents.

a

ANOVA.

b

Chi-square.

c

Fisher's exact test.